10-K Decoder · All companies

Immunome, Inc.

IMNM · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$6.94M$9.04M−23.2%
Operating income−$224M−$306M+26.7%
Net income−$212M−$293M+27.5%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$90.4M−$60.1M−50.4%
Net income−$85.8M−$57.5M−49.2%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Immunome's revenue in FY2025?
$6.94M in FY2025 (Fiscal year ended Dec 31, 2025), −23.2% vs $9.04M a year earlier, per its 10-K filed Mar 2026.
Was Immunome profitable in FY2025?
No: net income was −$212M and operating income −$224M in FY2025.
What was Immunome's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 9, 2026.